Development - New Investigators

发展 - 新研究者

• 批准号: 7726769
• 负责人: MICHAEL J. WEBER
• 金额: $ 5.15万
• 依托单位: UNIVERSITY OF VIRGINIA
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/7726769
• 关键词: Area; Basic Science; Biological Markers; Biomedical Engineering; Cancer Center; Cancer Center Support Grant; Cancer Control; Clinical Investigator; Clinical Trials; Development; Environment; Equipment; Foundations; Funding; Future; Health Sciences; Image; Immunotherapy; Individual; Investments; Malignant Neoplasms; Malignant neoplasm of prostate; Movement; Public Health; Radiology Specialty; Recruitment Activity; Research; Research Personnel; Scientist; Solid Neoplasm; Translational Research; Universities; Virginia; Wages; Woman; Work; cancer imaging; cost; interest; medical schools; oncology

New Investigators. We are requesting $150,000 per year to support 2-3 new investigators for one to three years for start-up of their research. The recruitments occur in partnership with Departments, and can be initiated by either partner. The funds are intended to guarantee technical support and supplies for junior-level investigators. However, it is possible that these funds could be combined into a larger package for a more senior individual. The University of Virginia will pay for the salary and most of the equipment costs of these recruits, and in addition the Cancer Center has available $500,000 per year from the School of Medicine to aid in recruitment. Further matching almost invariably is obtained from the Department that we partner with in these recruitments. Thus, funds from the CCSG permit the Cancer Center to leverage a relatively modest investment into a considerable influence on the future of the University of Virginia Health Sciences Center. As described in Section 6.3, our focus for recruitments during the next funding period will be to bolster clinical investigations, strengthen cancer-focused basic and translational research, and strengthen Cancer Control. Clinical investigators will be chosen who will work well within our collaborative environment, and who have an interest and expertise in molecularly targeted therapies, biomarkers, and imaging, especially in the major solid tumors. Translational investigators will be recruited to help development of translational working groups, especially in the areas of immunotherapy, women's oncology, prostate cancer, and aerodigestive cancers. In addition, we will look for opportunities to partner with basic science departments, to recruit outstanding cancer-focused basic scientists, with the Departments of Biomedical Engineering and Radiology to bolster our capability in cancer imaging, and with the Department of Public Health Sciences, to strengthen the foundation for movement toward Comprehensive status.

新调查人员。 我们要求每年$ 150,000，以支持2-3个新调查人员一到三年 为了启动他们的研究。招聘与部门合作发生，可以 由任何一个合作伙伴发起。资金旨在保证技术支持和 初级调查人员的供应。但是，这些资金可能是 合并为一个更大的人，以提供更高的个人。弗吉尼亚大学将付款 对于这些新兵的薪水和大多数设备费用，此外 中心每年从医学院获得500,000美元，以帮助招聘。 我们与我们合作的部门获得了进一步的匹配 这些招募。因此，CCSG的资金允许癌症中心利用 对对大学未来产生的重大影响的相对适度的投资 弗吉尼亚健康科学中心。 如第6.3节所述，我们在下一个资金期间招募的重点将是 为了提高临床研究，加强了以癌为中心的基本和转化研究， 并加强癌症控制。将选择临床调查人员在其中工作得很好 我们的协作环境，并且对分子有兴趣和专业知识 疗法，生物标志物和成像，尤其是在主要实体瘤中。翻译 调查人员将被招募以帮助发展转化工作组，尤其是在 免疫疗法，妇女肿瘤学，前列腺癌和机械化癌的领域。在 此外，我们还将寻找与基础科学部门合作的机会，招募 以癌症为重点的基础科学家，生物医学工程系 和放射学以增强我们在癌症成像中的能力，并与公众部门 健康科学，以加强朝着全面地位运动的基础。